Literature DB >> 3009364

Speculations on sequence homologies between the fibronectin cell-attachment site, major histocompatibility antigens, and a putative AIDS virus polypeptide.

C Auffray, J Novotny.   

Abstract

The core of the fibronectin cell-attachment site has been shown to be the tetrapeptide sequence Arg-Gly-Asp-Ser (RGDS). This peptide as well as its inverted analogue Ser-Asp-Gly-Arg (SDGR) efficiently inhibit fibronectin-mediated cell attachment in vivo and in vitro. Homology searches in protein data banks revealed the presence of the peptide SDGR in the alpha 2 domain of MHC class I antigens, and a variant of RGDS, Arg-Phe-Asp-Ser (RFDS), was found highly conserved in MHC class I (alpha 1 domain) and class II antigens (beta 1 domain). Three-dimensional models of MHC class I antigens suggested that the two tetrapeptide sequences may be located at the surface of the molecule, readily available for intermolecular contacts. We propose that fibronectin-mediated and MHC-mediated cell-cell interactions have similar molecular bases and that the RGDS-like sequences participate in specific cell adhesion between lymphoid cells. The RFDS tetrapeptide was also found in the sequence of a putative polypeptide chain encoded by the HTLVIII/LAV retrovirus family, the causative agent of AIDS. These amino acid sequence homologies suggest a common molecular basis for specific interactions between the MHC class II antigens, or the AIDS virus, and the T -cell specific T4 glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009364     DOI: 10.1016/0198-8859(86)90015-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  The CD3 gamma-chain, transmembrane signalling or recognition?

Authors:  B Levins; C A Colaco
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Computational simulations of the conformational behaviour of the adhesive proteins RGDS fragment.

Authors:  M Cotrait; M Kreissler; J Hoflack; J M Lehn; B Maigret
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

Review 3.  Functional sites of human class I MHC molecules: paradigms a dozen?

Authors:  P Parham
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes.

Authors:  J A Young; D Wilkinson; W F Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Evolution of the major histocompatibility complex: Isolation of class II beta cDNAs from two monotremes, the platypus and the short-beaked echidna.

Authors:  Katherine Belov; Mary K P Lam; Lars Hellman; Donald J Colgan
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

6.  Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial.

Authors:  Hannah V Siddle; Alexandre Kreiss; Mark D B Eldridge; Erin Noonan; Candice J Clarke; Stephen Pyecroft; Gregory M Woods; Katherine Belov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

7.  Molecular cloning and characterization of the polymorphic MHC class II DBB from the tammar wallaby (Macropus eugenii).

Authors:  Teena L Browning; Katherine Belov; Robert D Miller; Mark D B Eldridge
Journal:  Immunogenetics       Date:  2004-01-30       Impact factor: 2.846

8.  Lymphocyte major histocompatibility complex-encoded class II structures may act as sperm receptors.

Authors:  E R Ashida; V L Scofield
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  An epitope common to HLA class I and class II antigens, Ig light chains, and beta 2-microglobulin.

Authors:  P M Lutz; P Cresswell
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Isolation of chicken major histocompatibility complex class II (B-L) beta chain sequences: comparison with mammalian beta chains and expression in lymphoid organs.

Authors:  Y Bourlet; G Béhar; F Guillemot; N Fréchin; A Billault; A M Chaussé; R Zoorob; C Auffray
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.